Výsledky vyhledávání - "céline Bourgier"

Akademický článek

Evaluation of Ethos intelligent optimization engine for left locally advanced breast cancer

Autor: Jessica Prunaretty, Laura Lopez, Morgane Cabaillé, Céline Bourgier, Aurélie Morel, David Azria, Pascal Fenoglietto

Publikováno v: Frontiers in Oncology, Vol 14 (2024)

PurposeTo evaluate the feasibility to use a standard Ethos planning template to treat left-sided breast cancer with regional lymph nodes.Material/MethodsThe tuning cohort of 5 patients was used to create a planning template. The validation cohort inc

Externí odkaz: https://doaj.org/article/d90480f1e50b435bbd69389daa154ba6

Zobrazit plný text záznamu

Akademický článek

Feasibility study of adaptive radiotherapy with Ethos for breast cancer

Autor: Arthur Galand, Jessica Prunaretty, Nicolas Mir, Aurélie Morel, Céline Bourgier, Norbert Aillères, David Azria, Pascal Fenoglietto

Publikováno v: Frontiers in Oncology, Vol 13 (2023)

PurposeThe aim of this study was to assess the feasibility of online adaptive radiotherapy with Ethos for breast cancer.Materials and methodsThis retrospective study included 20 breast cancer patients previously treated with TrueBeam. All had undergo

Externí odkaz: https://doaj.org/article/3f68bb2260984c329417af4ffcddf7f9

Zobrazit plný text záznamu

Akademický článek

Efficacy, safety, and feasibility of volumetric modulated arc therapy for synchronous bilateral breast cancer management

Autor: Stanislas Quesada, Pascal Fenoglietto, Sophie Gourgou, Claire Lemanski, Roxana Draghici, Norbert Ailleres, Jessica Prunaretty, David Azria, Céline Bourgier

Publikováno v: Frontiers in Oncology, Vol 12 (2022)

PurposeVolumetric Modulated Arc Therapy (VMAT) exhibits potent advantages regarding target volume coverage and protection of organs at risk, notably in the context of anatomical constraints. Nevertheless, reports concerning VMAT for the treatment of

Externí odkaz: https://doaj.org/article/6a40880478794462a019250039d0b0ca

Zobrazit plný text záznamu

Abstract P1-10-13: Economic comparison of standard external beam whole breast (WBI) versus accelerated partial breast irradiation (ABPI) in postmenopausal women with early-stage breast cancer. Results from the French SHARE randomized trial

Autor: Alicia Le Bras, Yazid Belkacemi, céline Bourgier, Isabelle Gabelle-Flandin, Adeline Petit, Philippe Guilbert, Julien Geffrelot, Christian Carrie, Eleonor RIVIN DEL CAMPO, Chantal Hanzen, claire charra-brunaud, Guillaume Auzac, Thomas Lacornerie, Jérôme Lemonnier, Eric Lartigau, Isabelle Durand-Zaleski

Publikováno v: Cancer Research. 83:P1-10

Purpose: The economic evaluation reports the incremental cost utility ratio and budget impact of APBI vs standard external beam WBI for the treatment of post-menopausal women with early stage breast cancer. Methods and materials: We compared 488 wome

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e8b0830df58c785b32d9c75bacc0dcc2
https://doi.org/10.1158/1538-7445.sabcs22-p1-10-13

Zobrazit plný text záznamu

Abstract PD3-05: Early results of the French multicenter, randomized SHARE trial comparing whole breast irradiation versus accelerated partial breast irradiation in postmenopausal women with early-stage breast cancer

Publikováno v: Cancer Research. 83:PD3-05

Purpose: The aim of current analyses is to report toxicity and cosmetic outcomes at 3 and up to 9 years of follow-up of post-menopausal patients randomized to receive either standard external beam whole breast radiotherapy (WBI), including hypofracti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::506483c8e0c00c2404a946a7e4bba76e
https://doi.org/10.1158/1538-7445.sabcs22-pd3-05

Zobrazit plný text záznamu

Akademický článek

Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity

Autor: Jérôme Lacombe, Muriel Brengues, Alain Mangé, Céline Bourgier, Sophie Gourgou, André Pèlegrin, Mahmut Ozsahin, Jérôme Solassol, David Azria

Publikováno v: Radiation Oncology, Vol 14, Iss 1, Pp 1-11 (2019)

Abstract Background Biomarkers for predicting late normal tissue toxicity to radiotherapy are necessary to personalize treatments and to optimize clinical benefit. Many radiogenomic studies have been published on this topic. Conversely, proteomics ap

Externí odkaz: https://doaj.org/article/6467dd72a28346129ffe48e7196fef29

Zobrazit plný text záznamu

Plný text ve formátu HTML

Abstract P3-19-01: CANTO RT: The largest prospective multicenter cohort of early breast cancer patients treated with radiotherapy including full DICOM RT data

Publikováno v: Cancer Research. 82:P3-19

Purpose: In this paper, we describe the methodology used, and provide a first characterization of the study population and radiotherapy (RT) data in CANTO-RT (CANcer TOxicities Radiotherapy), the largest available multicenter prospective cohort of ea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fcf1f9207c193770c906016f4e5178d4
https://doi.org/10.1158/1538-7445.sabcs21-p3-19-01

Zobrazit plný text záznamu

Abstract P4-11-07: Improfib: Impact of radiotherapy on fatigue in breast cancer survivors

Publikováno v: Cancer Research. 82:P4-11

Background Fatigue is a common and disabling symptom experienced by patients (pts) after breast cancer (BC) treatment, significantly impacting their quality of life. However, this complex and multidimensional symptom often remains poorly managed. Pre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::81cfa7bc282fb5618702813349169c44
https://doi.org/10.1158/1538-7445.sabcs21-p4-11-07

Zobrazit plný text záznamu

Akademický článek

Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors

Autor: Alexandre Thibault Jacques Maria, Léo Partouche, Radjiv Goulabchand, Sophie Rivière, Pauline Rozier, Céline Bourgier, Alain Le Quellec, Jacques Morel, Danièle Noël, Philippe Guilpain

Publikováno v: Frontiers in Immunology, Vol 9 (2019)

Systemic sclerosis (SSc) is an autoimmune connective tissue disorder, characterized by multisystem involvement, vasculopathy, and fibrosis. An increased risk of malignancy is observed in SSc (including breast and lung cancers), and in a subgroup of p

Externí odkaz: https://doaj.org/article/586c3a65eaca4280b33d3016ff1f27c4

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání